Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Psychiatric disorders are common and can be severe. There is a need to identify biomarkers of psychiatric disorders to better diagnose and treat patients with psychiatric symptoms. Magnetic resonance spectroscopy (MRS) is a tool used to measure the levels of various metabolites in the human brain, and MRS studies of psychiatric disorders have identified potentially useful biomarkers of psychiatric illness. There have been significant advances in the way that psychiatric disorders are understood, classified, and researched as well as improvements in magnetic resonance imaging/MRS technology. MRS as a tool has not yet proved helpful to individual patients with psychiatric symptoms.

Original languageEnglish (US)
Pages (from-to)25-33
Number of pages9
JournalNeuroimaging Clinics of North America
Issue number1
StatePublished - Feb 2020


  • Brain
  • Magnetic resonance spectroscopy
  • Meta-analysis
  • Psychiatric disorder
  • Psychiatry
  • Psychoradiology
  • Review

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology


Dive into the research topics of 'Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade'. Together they form a unique fingerprint.

Cite this